Safety and Efficacy of Genolimzumab (GB226) in Combination With Fruquintinib

NCT03976856 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

42

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Non-small Cell Lung Cancer

Interventions

DRUG: GB226
DRUG: Fruquintinib

Sponsor

Genor Biopharma Co., Ltd.

Collaborators

[object Object]